Premium
Indications for in vitro fertilization at a public center for reproductive health in Campinas, Brazil
Author(s) -
Pantoja Marcia,
Fernandes Arlete
Publication year - 2015
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2014.07.022
Subject(s) - medicine , infertility , in vitro fertilisation , gynecology , obstetrics , endometriosis , referral , tubal factor infertility , pelvic inflammatory disease , public health , ectopic pregnancy , tubal ligation , pregnancy , population , family medicine , family planning , environmental health , nursing , research methodology , genetics , biology
Objective To assess the sociodemographic profile and gynecologic and obstetric characteristics of women referred to a public reference center in Campinas, Brazil, for in vitro fertilization (IVF). Methods Women referred between April 1, 2008, and October 31, 2009, were eligible for inclusion in a cross‐sectional study. Participants were interviewed about sociodemographic characteristics, obstetric and gynecologic history, and etiologic factors resulting in the referral. Preliminary clinical examinations performed elsewhere were evaluated. Results A total of 176 women were included, of whom 129 (73.3%) presented with tubal factor infertility. Tubal ligation had been performed in 66 (37.5%) women. Overall, 121 (68.8%) women were aged 30 years old or less, 110 (62.5%) had received more than 8 years of schooling, 123 (69.6%) had had infertility for up to 5 years, and 99 (56.3%) did not have any children. Moreover, 25 (14.2%) women had endometriosis and 25 (14.2%) had a male factor issue. A previous ectopic pregnancy was reported for 20 (11.4%) women and pelvic inflammatory disease for 49 (27.8%). Conclusion Tubal factor infertility was the most common indication for IVF. Preventive measures are required, in addition to policies that ensure access to high‐complexity treatments in the public sector.